semaglutide phase 3 Three new REIMAGINE studies provide some of the strongest evidence yet for CagriSema® (cagrilintide + semaglutide) in type 2 diabetes. 🔹 REIMAGINE 1 Studied people with early type 2 diabetes Semaglutide phase 3 SUSTAIN trials

doi: 10.1161/HYPERTENSIONAHA.109.130203 31 HermidaRCCrespoJJDominguez-SardinaMOteroAMoyaARiosMTet al

For context, most GLP-1 medications require consistent use for weeks or months to start working at full therapeutic capacity

GLP-1 agonists are a group of medications that help to manage blood sugar in people with Type 2 diabetes, some of which can be used to treat obesity even in people who do not have diabetes

This attitude shift creates a more receptive environment for medications like Retatrutide that offer meaningful efficacy

Should I monitor my blood sugar levels after stopping semaglutide

Gastrointestinal side effects such as nausea may indirectly disrupt sleep, and obesity itself the condition being treated is a common cause of poor sleep quality